TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Vistin Pharma ASA
Closing information (x1000 DKK)
Closing information | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Turnover |
203,226
|
205,647
|
179,106 |
Financial expenses |
6,687
|
5,459
|
130,101 |
Earnings before taxes |
-4,244
|
23,856
|
-87,920 |
Total assets |
287,673
|
248,396
|
227,750 |
Current assets |
112,453
|
102,768
|
100,127 |
Current liabilities |
83,215
|
30,596
|
22,784 |
Equity capital |
193,045
|
205,614
|
192,722 |
- share capital |
31,327
|
33,064
|
31,373 |
Employees (average) |
0
![]() |
0 |
Financial ratios
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Solvency |
67.1%
|
82.8%
|
84.6% |
Turnover per employee | |||
Profit as a percentage of turnover |
-2.1%
|
11.6%
|
-49.1% |
Return on assets (ROA) |
0.8%
|
11.8%
|
18.5% |
Current ratio |
135.1%
|
335.9%
|
439.5% |
Return on equity (ROE) |
-2.2%
|
11.6%
|
-45.6% |
Change turnover |
8,381
|
16,890
|
17,708 |
Change turnover % |
4%
|
9%
|
11% |
Chg. No. of employees | 0 | ||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.